APA (7th ed.) Citation

SB, W., T, W., M, H., JJ, M., RA, B., E, K., . . . TE, W. (2020). Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press.

Chicago Style (17th ed.) Citation

SB, Wigal, Wigal T, Hobart M, Madera JJ, Baker RA, Kohegyi E, McKinney A, and Wilens TE. Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press, 2020.

MLA (8th ed.) Citation

SB, Wigal, et al. Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies. Dove Medical Press, 2020.